Publication Name	World Journal of Clinical Cases
Manuscript ID	88475
Country	China

Received	2023-10-08 01:56
Peer-Review Started	2023-10-08 01:58
First Decision by Editorial Office Director	2023-12-01 18:15
Return for Revision	2023-12-04 00:36
Revised	2024-01-02 02:50
Publication Fee Transferred
Second Decision by Editor	2024-02-05 02:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-02-05 06:56
Articles in Press	2024-02-05 06:56
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-25 05:39
Publish the Manuscript Online	2024-03-01 02:45

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Dan Wu, Qiong Wang, Shuai Yan, Xia Sun, Ya Qin, Ming Yuan, Nan-Yao Wang and Xian-Ting Huang
ORCID	Author(s) ORCID Number Qiong Wang http://orcid.org/0009-0001-1157-7302
Funding Agency and Grant Number	Funding Agency Grant Number Wuxi Health and Health Committee MS201908
Corresponding Author	Qiong Wang, MD, Chief Doctor, Professor, Department of Oncology, Jiangyin People's Hospital, No. 163, Shoushan Road, Wuxi 214400, Jiangsu Province, China. wangqiong55@hotmail.com
Key Words	Pancreatic cancer; Anti-vascular endothelial growth factor receptor; Fruquintinib; Case report
Core Tip	These two cases achieved a progress-free survival benefit from later-line single-agent fruquintinib therapy. With its better safety profile, fruquintinib may be worth exploring and studying in more depth as a later-line treatment for pancreatic cancer patients. This is the first literary report on Fruquintinib used in metastasis pancreatic cancers.
Publish Date	2024-03-01 02:45
Citation	Wu D, Wang Q, Yan S, Sun X, Qin Y, Yuan M, Wang NY, Huang XT. Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports. World J Clin Cases 2024; 12(7): 1296-1304
URL	https://www.wjgnet.com/2307-8960/full/v12/i7/1296.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i7.1296

Full Article (PDF)	WJCC-12-1296-with-cover.pdf
CARE Checklist–2016	88475-CARE Checklist (2016).pdf
Manuscript File	88475_Auto_Edited-LJH-YJP.docx
Answering Reviewers	88475-Answering reviewers.pdf
Audio Core Tip	88475-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	88475-Conflict-of-interest statement.pdf
Copyright License Agreement	88475-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	88475-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	88475-Language certificate.pdf
Peer-review Report	88475-Peer-review(s).pdf
Scientific Misconduct Check	88475-Bing-Liu JH-2.png
Scientific Misconduct Check	88475-CrossCheck.png
Scientific Editor Work List	88475-Scientific editor work list.pdf
CrossCheck Report	88475-CrossCheck report.pdf